Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

What is causing the mortality in treating the anemia of chronic kidney disease: erythropoietin dose or hemoglobin level?

What is causing the mortality in treating the anemia of chronic kidney disease: erythropoietin dose or hemoglobin level? Curr Opin Nephrol Hypertens. 2010 Sep; 19(5):420-4.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.